Allogeneic blood or marrow transplantation using haploidentical grandchildren donors and post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis

Documents similaires

• Effect of peptide‐binding motif on survival of HLA‐haploidentical transplantation with post‐transplant cyclophosphamide
  par: Kentaro Ido, et autres
  Publié: (2024)
• Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post‐transplantation cyclophosphamide for adult T‐cell leukaemia/lymphoma
  par: Makoto Yoshimitsu, et autres
  Publié: (2024)
• Graft‐versus‐host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post‐transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation
  par: Avichai Shimoni, et autres
  Publié: (2025)
• Clinical outcomes of modified post‐transplantation cyclophosphamide versus granulocyte colony‐stimulating factor/anti‐thymocyte globulin‐based protocol in alternative donor transplantation for severe aplastic anaemia
  par: Liangliang Wu, et autres
  Publié: (2025)
• Impact of graft‐versus‐host disease prophylaxis strategies on GvHD ‐free/relapse‐free survival in young adults undergoing unrelated donor allogeneic haematopoietic cell transplantation: A propensity score‐matched analysis
  par: Nihar Desai, et autres
  Publié: (2025)